ENLV: Enlivex Therapeutics Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27.28
Enterprise Value ($M) 26.46
Book Value ($M) 30.08
Book Value / Share 1.60
Price / Book 0.91
NCAV ($M) 27.02
NCAV / Share 1.44
Price / NCAV 1.01

Profitability (mra)
Return on Invested Capital (ROIC) -0.93
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.57

Liquidity (mrq)
Quick Ratio 5.57
Current Ratio 5.57

Balance Sheet (mrq) ($M)
Current Assets 33.76
Assets 36.83
Liabilities 6.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -25.15
Net Income -29.07

Cash Flow Statement (mra) ($M)
Cash From Operations -23.52
Cash from Investing -25.97
Cash from Financing 0.36

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 17,278 8,798 196.39
2024-04-25 4,368 11,551 37.81
2024-04-24 37,594 24,451 153.75
2024-04-23 4,881 12,476 39.12

(click for more detail)

Similar Companies
EFTR – eFFECTOR Therapeutics, Inc. ELDN – Eledon Pharmaceuticals, Inc.
ELUT – Elutia Inc. ENSC – Ensysce Biosciences, Inc.
ENTX – Entera Bio Ltd.


Financial data and stock pages provided by
Fintel.io